Study predicts rising Obamacare premiums in 2017
Premiums for popular low-cost medical plans under the federal health care law are expected to go up an average of 11 percent next year, says a new study. But not in Indianapolis.
Premiums for popular low-cost medical plans under the federal health care law are expected to go up an average of 11 percent next year, says a new study. But not in Indianapolis.
Indianapolis-based Simon Property Group Inc. and Warsaw’s Zimmer Biomet Holdings vaulted back among the top 500 this year, while local oil refiner Calumet Specialty Products Partners plummeted.
One of Indiana’s largest home health care providers, facing allegations that it put patients in immediate jeopardy, has agreed to be acquired by a competing company in a deal that could be worth as much as $3 million.
Indiana-based Zimmer Biomet Holdings Inc. has agreed to buy LDR Holding Corp. for about $1 billion in cash to add surgical technologies for the treatment of patients with spine disorders.
The competition heated up in the $71.5 billion global diabetes market last year after Indianapolis-based Eli Lilly’s and Boehringer Ingelheim’s Jardiance unexpectedly reduced the risk of heart attacks, strokes and deaths in a study.
State health officials are urging Indiana's health care providers to aggressively test patients for syphilis.
Anthem, one of Indiana’s largest insurers, is seeking premium hikes ranging from nearly 20 percent to 41 percent for coverage it sells on and off the Affordable Care Act’s public insurance exchanges.
Indiana's attorney general says in a brief filed Wednesday that the court should deny Planned Parenthood of Indiana and Kentucky's request for a preliminary injunction preventing the law from taking effect July 1.
The state’s Family and Social Services Administration is set to cut home health care Medicaid reimbursements for licensed practical nurses, registered nurses, aides, therapists and pathologists.
Biochemist has founded or co-founded five startups since retiring from Eli Lilly and Co. as head of biotechnology research 13 years ago, at age 50.
The Indianapolis-based drugmaker said Tuesday it has built a robust pipeline of drugs that “has the potential” to launch 20 new products in the 10 years between 2014 and 2023.
The sector is undergoing a wave of consolidation, driven in part by falling crop prices, which have reduced farmers' spending on genetically enhanced seeds. Locally based Dow AgroSciences is merging with DuPont’s ag unit, and ChemChina is buying Syngenta.
A court-appointed patient care ombudsman who looked into Nightingale Home Healthcare’s operations says he found more than 1,300 complaints from patients and family members since 2011.
Springbuk, which aims to simplify the jobs of HR benefits and wellness managers, plans to use the money on product innovation and hiring.
A Carmel surgery center is joining others in the state in suing UnitedHealthcare, alleging it unlawfully withheld payment for some services to make up for overpayment of other claims.
The Supreme Court failed to resolve a knotty dispute between faith-based groups and the Obama administration over birth control on Monday.
Indiana is one of several states involved in legal battles over the storage of blood samples. The cases pose a dilemma: How can society balance the right to privacy with the needs of science and medical research?
The founder of AIT Laboratories, along with his insurance companies and bank, will pay back more than $3 million to employees who bought the company from him six years ago at what the government said was an inflated price.
The Indiana Blood Center said it has been forced to defer up to 30 percent of donors at some post-spring break blood drives because they had traveled to areas where the Zika virus is being transmitted.
A federal judge made the award to Lilly’s former executive director of human resources, who quit for health reasons and was later dropped from the company’s extended disability plan.